Chemed Corp (NYSE:CHE)
$ 564.785 2.735 (0.49%) Market Cap: 8.46 Bil Enterprise Value: 8.31 Bil PE Ratio: 28.54 PB Ratio: 6.85 GF Score: 94/100

Chemed Corp at Credit Suisse Healthcare Conference Transcript

Nov 09, 2022 / 10:00PM GMT
Release Date Price: $488.62 (-0.20%)
Albert J. William Rice;dit Suisse AG
CrÃ;Research Division - Research Analyst

© -

Hi, everybody. I'm A.J. Rice, healthcare service analyst at Credit Suisse. We're really pleased to have next up, once again presenting at our conference is Chemed. We have Kevin McNamara, President and CEO. We have Nick Westfall, President and CEO of the VITAS subsidiary.

Questions & Answers

Albert J. William Rice;dit Suisse AG
CrÃ;Research Division - Research Analyst

© -

Kevin, we're 5 months or -- 5 months, I'm losing it here. We're 11 months into the year. It's been quite the year. What would you say have been some of the wins for Chemed this year? And where have been some of the challenges maybe just to level set everyone?

Kevin J. McNamara
Chemed Corporation - CEO, President & Director

Okay. Let me start then and say it's come in pretty much as guided, as expected. Roto-Rooter, another solid year on top of 2 fantastic years during the pandemic. And the comment on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot